Fig 1.
Flow chart representing the study selection process.
Table 1.
Baseline patient characteristics of the RP and EBRT groups in all patients (n = 891).
Fig 2.
Survival curves depicting overall survival in the radical prostatectomy (RP) and external beam radiotherapy (EBRT) groups, in (A) all (P <0.0001), (B) low-risk (P = 0.1366), (C) intermediate-risk (P = 0.0067), and (D) high-risk patients (P = 0.0001), respectively.
Each P-value indicates the result of log-rank test.
Fig 3.
Survival curves depicting cancer-specific survival in the radical prostatectomy (RP) and external beam radiotherapy (EBRT) groups, in (A) all (P = 0.0010), (B) low-risk (P <0.0001), (C) intermediate-risk (P = 0.1820), and (D) high-risk patients (P = 0.0233), respectively.
Each P-value indicates the result of log-rank test.
Fig 4.
Other-cause mortality in the radical prostatectomy (RP) and external beam radiotherapy (EBRT) groups (log-rank test, P = 0.0001).
Table 2.
Baseline patient characteristics of the RP and EBRT groups in high-risk patients (n = 336).
Table 3.
Univariate and multivariate analyses of clinicopathological factors for cancer-specific survival.
Fig 5.
Survival curves depicting biochemical recurrence-free survival in the radical prostatectomy (RP) and external beam radiotherapy (EBRT) groups, in (A) all (P <0.0001), (B) low-risk (P = 0.0230), (C) intermediate-risk (P = 0.0030), and (D) high-risk patients (P = 0.0025), respectively.
Each P-value indicates the result of log-rank test.